A Council of Scientific and Industrial Research (CSIR) laboratory on Sunday launched a scientifically validated anti-diabetes herbal drug called "BGR-34" in Lucknow, reported The Times of India.
According to the report, the drug has been developed by the National Botanical Research Institute (NBRI) and the Central Institute for Medicinal and Aromatic Plant (CIMAP), both CSIR labs, and will be commercially manufactured and marketed by M/s Aimil Pharamaceuticals Pvt Ltd, New Delhi.
"The drug has extracts from four plants mentioned in ayurveda and that makes it safe," Dr AKS Rawat, senior principal scientist, NBRI, told TOI.
The clinical trial for the drug, which has been tested on animals and found safe after scientific studies, has shown 67% success.
The TOI report further states, "The drug boosts the immune system, works as an antioxidant and checks free radicals. Though there are other anti-diabetes herbal drugs in the market, `BGR-34' has been validated scientifically. The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels."
The drug is expected to be available in the market in the next 15 days and is likely to cost Rs 500 for 100 tablets, adds the report.